| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |